Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H OERTEL

Showing results (401-410 of 678) with videos related to

Pageof 68
Sort By:
Neurology|June 1, 1994
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's diseaseJ Schwarz, A Antonini, E Kraft, et al.
Advances in Neurology|September 14, 2001
Depression in Parkinson's disease. An updateW H Oertel, G U Höglinger, T Caraceni, et al.
Neurology|May 1, 1996
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in GermanyA Seidler, W Hellenbrand, B P Robra, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
GABA markers in the hypothalamic median eminenceM L Tappaz, M Aguera, M F Belin, et al.
Neuroscience|April 21, 2015
Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian miceU Keber, M Klietz, T Carlsson, et al.
Annals of Neurology|December 1, 1992
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's diseaseW H Oertel, K Tatsch, J Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patientsRebecca C Selter, Viola Biberacher, Verena Grummel, et al.
Epilepsy & Behavior : E&B|January 23, 2010
Memory for public events in patients with unilateral temporal lobe epilepsyAnja Haag, Sonja Barth, Maja Zibelius, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Health-related quality of life in patients with Gilles de la Tourette's syndromeKirsten Müller-Vahl, Ines Dodel, Norbert Müller, et al.
BMC Neurology|October 2, 2025
Acetyl-DL-leucine (Tanganil™) in three patients with advanced multiple system atrophyWolfgang H Oertel, Martin T Henrich, Elisabeth Sittig, et al.
Pageof 68

Showing results (401-410 of 678) with videos related to

Sort By:
Pageof 68
Neurology|June 1, 1994
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's diseaseJ Schwarz, A Antonini, E Kraft, et al.
Advances in Neurology|September 14, 2001
Depression in Parkinson's disease. An updateW H Oertel, G U Höglinger, T Caraceni, et al.
Neurology|May 1, 1996
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in GermanyA Seidler, W Hellenbrand, B P Robra, et al.
Advances in Biochemical Psychopharmacology|January 1, 1981
GABA markers in the hypothalamic median eminenceM L Tappaz, M Aguera, M F Belin, et al.
Neuroscience|April 21, 2015
Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian miceU Keber, M Klietz, T Carlsson, et al.
Annals of Neurology|December 1, 1992
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's diseaseW H Oertel, K Tatsch, J Schwarz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patientsRebecca C Selter, Viola Biberacher, Verena Grummel, et al.
Epilepsy & Behavior : E&B|January 23, 2010
Memory for public events in patients with unilateral temporal lobe epilepsyAnja Haag, Sonja Barth, Maja Zibelius, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Health-related quality of life in patients with Gilles de la Tourette's syndromeKirsten Müller-Vahl, Ines Dodel, Norbert Müller, et al.
BMC Neurology|October 2, 2025
Acetyl-DL-leucine (Tanganil™) in three patients with advanced multiple system atrophyWolfgang H Oertel, Martin T Henrich, Elisabeth Sittig, et al.
Pageof 68